# Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) – FDA Inspection, Mar 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/98b9736f-c6d4-4c5c-9113-69846725a990
Source feed: FDA_Inspections

> FDA inspection 1084107 of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant), March 22, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084107
- Company Name: Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- Inspection Date: 2019-03-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1261674 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/c4db414c-686b-4498-a4b8-2022ce9c30ef)
- FDA Inspection 981968 - 2016-07-22
- FDA Inspection 866095 - 2013-12-20
- FDA Inspection 582495 - 2009-04-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-t-middendorf/0fea23f5-ffe6-49a0-ac33-780317707c71)

Company: https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
